Trial Profile
Natalizumab Effects on Parameters of Sleep in Patients With Relapsing Forms of Multiple Sclerosis Experiencing Fatigue or Sleepiness
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Jun 2015
Price :
$35
*
At a glance
- Drugs Natalizumab (Primary)
- Indications Multiple sclerosis
- Focus Pharmacodynamics
- Acronyms NAPS-MS
- 28 Jan 2014 Status changed from recruiting to completed as reported by Clinicaltrials.gov record.
- 09 May 2012 New trial record